New Product Launches
Various
Development/FilingActive
Key Facts
About FDC India
FDC Limited is a prominent Indian pharmaceutical player with a legacy dating back to 1936, focusing on developing, manufacturing, and marketing a wide range of pharmaceutical formulations. The company has established a robust commercial footprint in India and over 50 other countries, leveraging its expertise in branded generics and OTC segments. Its strategic direction emphasizes portfolio expansion in chronic therapies, geographical diversification, and strengthening its API vertical to ensure cost competitiveness and supply chain resilience.
View full company profileTherapeutic Areas
Other Various Drugs
| Drug | Company | Phase |
|---|---|---|
| Biosimilar Programs | Richter Gedeon | Phase 3 |
| Oligonucleotide APIs | Bachem | Clinical/Commercial |
| Novel Plasma-derived Therapies | Tiantan Bio | Pre-clinical |
| Complex Injectable Generics Pipeline | Amphastar Pharmaceuticals | ANDA Filed / Development |
| Generic Portfolio | Strides Pharma | Approved |
| Generic Products Portfolio | Celon Pharma | Approved/Commercial |
| New Generic Filings (e.g., for US/EU) | Bliss GVS Pharma | Regulatory Review |
| Pipeline of Complex Generics | Mayne Pharma Group | Development |
| Bag APIs | ChemWerth | Approved |
| Oral APIs | ChemWerth | Approved |